SCHEMBL1170845

SCHEMBL1170845

O=S(=O)(O)c1cc(C=Cc2ccccc2)ccc1-c1ccc(C=Cc2ccccc2)cc1.[NaH].[NaH]

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 2/20 0.44
MAOB P27338 2/20 0.44
PTPN1 P18031 2/20 0.43
PTPN6 P29350 1/20 0.43
PELI1 Q96FA3 1/20 0.42
SRD5A1 P18405 1/20 0.41
SRD5A2 P31213 1/20 0.41
HNF4A P41235 1/20 0.41
RELA Q04206 1/20 0.40
PDK2 Q15119 1/20 0.38
TRPV1 Q8NER1 2/20 0.38
TTR P02766 2/20 0.38
CA1 P00915 1/20 0.38
MGLL Q99685 1/20 0.38
ALOX5 P09917 1/20 0.38
PTGS1 P23219 1/20 0.38
PTGS2 P35354 1/20 0.38
HSD17B10 Q99714 2/20 0.37
KDM4E B2RXH2 1/20 0.37
MEN1 O00255 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4238183 0.98 MAOA (0.45) MAOAMAOBPTPN1PTPN6PELI1
SCHEMBL11444848 0.92 MAOA (0.47) MAOAMAOBPTPN1PTPN6SRD5A1
SCHEMBL28532673 0.92 MAOA (0.47) MAOAMAOBPTPN1PTPN6SRD5A1
SCHEMBL27797862 0.90 MAOA (0.49) MAOAMAOBPTPN1PTPN6SRD5A1
SCHEMBL7590543 0.90 MAOA (0.49) MAOAMAOBPTPN1PTPN6SRD5A1
SCHEMBL8773475 0.82 MAOA (0.42) MAOAMAOBPTPN1PELI1SRD5A1
SCHEMBL1170842 0.81 MAOA (0.44) MAOAMAOBPTPN1PTPN6PELI1
SCHEMBL1170844 0.81 MAOA (0.44) MAOAMAOBPTPN1PTPN6PELI1
(Z)-1,2-Diphenylethene SCHEMBL27449534 0.80 PTPN1 (0.47) PTPN1PTPN6PELI1TRPV1TTR
SCHEMBL11366643 0.79 HTR2A (0.47) MAOAMAOBPTPN1HNF4ARELA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1555009-B1 Skin make-up composition OREAL (FR) 2010-07-14 EP claimed
US-7261744-B2 Method for dyeing or coloring human keratin materials with lightening effect using a composition comprising at least one fluorescent compound and at least one optical brightener L'OREAL S.A. (FR) 2007-08-28 US claimed
US-20060010617-A1 Method for dyeing or coloring human keratin materials with lightening effect using a composition comprising at least one fluorescent compound and at least one optical brightener L'OREAL S.A. (FR) 2006-01-19 US claimed
US-20050175562-A1 crosslinked organopolysiloxane having dimethylvinylsiloxy end groups and a methylhydropolysiloxane having trimethylsiloxy end groups; water, oil, water soluble sovlent as liquid binder; and goniochromatic / photochromic or fluorescent coloring agents; cosmetic L'OREAL S.A. (FR) 2005-08-11 US claimed
US-20050031559-A1 Mineral particles containing optical brightener for lightening the face skin; mixture of silica, hydroxyapatite particles and dyes of stilbene, or coumarin; foundation powders with concealing properties L'OREAL (FR) 2005-02-10 US claimed
EP-4593792-A1 COSMETIC HAIR CARE COMPOSITION COMPRISING AT LEAST ONE PARTICULAR AMINO SILICONE AND AT LEAST ONE COLOURING AGENT AND/OR AN OPTICAL BRIGHTENER, AND COSMETIC HAIR TREATMENT PROCESS L'OREAL (FR) 2025-08-06 EP disclosed
WO-2024068929-A1 COSMETIC HAIR CARE COMPOSITION COMPRISING AT LEAST ONE PARTICULAR AMINO SILICONE AND AT LEAST ONE COLOURING AGENT AND/OR AN OPTICAL BRIGHTENER, AND COSMETIC HAIR TREATMENT PROCESS L'OREAL (FR) 2024-04-04 WO disclosed
US-10173080-B2 Dehydroascorbic acid or monomeric, polymeric or isomeric derivative thereof and an amine for artificially coloring the skin L'OREAL (FR) 2019-01-08 US disclosed
US-20180140519-A1 ASSEMBLY AND PROCESS FOR MAKING UP A KERATIN MATERIAL L'OREAL (FR) 2018-05-24 US disclosed
US-9956147-B2 Emulsion containing a dispersion of bismuth oxychloride L'OREAL (FR) 2018-05-01 US disclosed
US-9643032-B2 Application of dehydroascorbic acid or derivatives/isomers thereof for artificially coloring the skin L'OREAL (FR) 2017-05-09 US disclosed
EP-3157635-A1 ASSEMBLY AND PROCESS FOR MAKING UP A KERATIN MATERIAL L'OREAL (FR) 2017-04-26 EP disclosed
US-20090016974-A1 Application of dehydroascorbic acid or derivatives/isomers thereof for artificially coloring the skin L'OREAL (FR) 2009-01-15 US disclosed
US-7261744-B2 Method for dyeing or coloring human keratin materials with lightening effect using a composition comprising at least one fluorescent compound and at least one optical brightener L'OREAL S.A. (FR) 2007-08-28 US disclosed
WO-2007042945-A2 PROCESS FOR MAKING UP OR CARING FOR THE NAILS WITH CYANOACRYLATE MONOMER L'OREAL (FR) 2007-04-19 WO disclosed
US-20070059269-A1 Administration of 8-hexadecene-1,16-dicarboxylic acid for promoting cohesion of the epidermal horny layer L'OREAL (FR) 2007-03-15 US disclosed
US-20060010617-A1 Method for dyeing or coloring human keratin materials with lightening effect using a composition comprising at least one fluorescent compound and at least one optical brightener L'OREAL S.A. (FR) 2006-01-19 US disclosed
US-20050175562-A1 crosslinked organopolysiloxane having dimethylvinylsiloxy end groups and a methylhydropolysiloxane having trimethylsiloxy end groups; water, oil, water soluble sovlent as liquid binder; and goniochromatic / photochromic or fluorescent coloring agents; cosmetic L'OREAL S.A. (FR) 2005-08-11 US disclosed
US-20050031559-A1 Mineral particles containing optical brightener for lightening the face skin; mixture of silica, hydroxyapatite particles and dyes of stilbene, or coumarin; foundation powders with concealing properties L'OREAL (FR) 2005-02-10 US disclosed
US-20040241115-A1 Nail varnish composition comprising fibers covered with at least one fluorescent whitening agent L'OREAL S.A. (FR) 2004-12-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090016974-A1 Application of dehydroascorbic acid or derivatives/isomers thereof for artificially coloring the skin ADH7, ADH1B, TYR MAOA 162/4885MAOB 150/4885PTPN1 2162/4885
US-20070059269-A1 Administration of 8-hexadecene-1,16-dicarboxylic acid for promoting cohesion of the epidermal horny layer DSG1, CUTA, DSC1 MAOA 3332/4885MAOB 4153/4885PTPN1 4803/4885
US-20040241115-A1 Nail varnish composition comprising fibers covered with at least one fluorescent whitening agent POLR1C, NACA, DPM1 MAOA 193/4885MAOB 652/4885PTPN1 192/4885
US-10173080-B2 Dehydroascorbic acid or monomeric, polymeric or isomeric derivative thereof and an amine for artificially coloring the skin OXER1, AKR1B10, RBP1 MAOA 759/4885MAOB 508/4885PTPN1 3083/4885
US-20060010617-A1 Method for dyeing or coloring human keratin materials with lightening effect using a composition comprising at least one fluorescent compound and at least one optical brightener KRT18, IK, CUTA MAOA 501/4885MAOB 1471/4885PTPN1 4822/4885
US-20050175562-A1 crosslinked organopolysiloxane having dimethylvinylsiloxy end groups and a methylhydropolysiloxane having trimethylsiloxy end groups; water, oil, water soluble sovlent as liquid binder; and goniochromatic / photochromic or fluorescent coloring agents; cosmetic MICA, MITF, CUTA MAOA 3648/4885MAOB 3669/4885PTPN1 3121/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.